Oliver Lagore Vanvalin Investment Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.94K | Buy |
+147
| New | +$9.94K | ﹤0.01% | 422 |
|
|
2024
Q4 | $6.59K | Sell |
147
-188
| -56% | -$8.42K | ﹤0.01% | 484 |
|
|
2024
Q3 | $21K | Sell |
335
-260
| -44% | -$16.3K | 0.01% | 339 |
|
|
2024
Q2 | $35.1K | Buy |
595
+247
| +71% | +$14.6K | 0.01% | 273 |
|
|
2024
Q1 | $27.7K | Sell |
348
-18
| -5% | -$1.44K | 0.01% | 302 |
|
|
2023
Q4 | $28.9K | Sell |
366
-872
| -70% | -$68.8K | 0.01% | 272 |
|
|
2023
Q3 | $86.4K | Buy |
1,238
+43
| +4% | +$3K | 0.03% | 179 |
|
|
2023
Q2 | $82.6K | Sell |
1,195
-81
| -6% | -$5.6K | 0.03% | 190 |
|
|
2023
Q1 | $94.8K | Sell |
1,276
-3,140
| -71% | -$233K | 0.04% | 127 |
|
|
2022
Q4 | $412K | Sell |
4,416
-796
| -15% | -$74.2K | 0.23% | 51 |
|
|
2022
Q3 | $497K | Sell |
5,212
-266
| -5% | -$25.4K | 0.32% | 50 |
|
|
2022
Q2 | $508K | Sell |
5,478
-353
| -6% | -$32.7K | 0.3% | 49 |
|
|
2022
Q1 | $586K | Sell |
5,831
-62,069
| -91% | -$6.24M | 0.39% | 47 |
|
|
2021
Q4 | $7M | Buy |
+67,900
| New | +$7M | 0.5% | 32 |
|